The French drugmaker joined several peers in promising new investments in U.S. drug production, but cautioned plans could ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

ADARx Pharmaceuticals will work with AbbVie to make RNA interference medicines for a variety of disease areas, including ...

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...